A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema)
Trial details
- Registry ID
- NCT07355075
- Phase
- Phase 2, Phase 3
Drug identity has not yet been verified against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema)NCT07355075 | Turn Therapeutics | Phase 2, Phase 3 | Recruiting | 2027-01-20Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |